https://www.selleckchem.com/pr....oducts/brivudine.htm
the reduction in response time is associated with improved patient outcomes for certain conditions.Purpose To report novel retinal findings in two male patients with mucopolysaccharidosis type II (Hunter syndrome) receiving long-term human recombinant idursulfase enzyme replacement therapy.Method Two males aged 19 and 26 years who had received enzyme replacement therapy for 12 and 13 years, respectively, with good compliance and no infusion-related reactions, were examined clinically and underwent optical coherence tomographic scannin
Like
Comment
Share
